EditorialPublished 9 October 2026Editorial: Cancer risk in patients with acromegaly – is extensive screening needed?, volume IIJakob Dal · Raluca Alexandra TrifanescuFrontiers in Endocrinologydoi 10.3389/fendo.2026.2004968
Case ReportPublished 8 October 2026Case Report: Case series: growth hormone replacement for severe growth hormone deficiency during BRAF inhibitor therapy in pediatric low-grade glioma: long-term follow-upMarta Panciroli · Antonio Verrico · Marco Crocco · Sara Cencioni · Chiara Morreale · Antonia Ramaglia · Valentina Iurilli · Gianluca Piccolo · Claudia Milanaccio · Mohamad Maghnie · Natascia Di IorgiFrontiers in Endocrinologydoi 10.3389/fendo.2026.1940850
Brief Research ReportPublished 30 September 2026Activating transcription factor 6 is involved in the beneficial effects of growth hormone-releasing hormone antagonists in the corneal endotheliumMd Matiur Rahman Sarker · Saikat Fakir · Madan Sigdel · Nektarios BarabutisFrontiers in Ophthalmologydoi 10.3389/fopht.2026.1946815
